These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11309336)

  • 21. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
    Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
    Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
    Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
    Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.
    Castells A; Gusella JF; Ramesh V; Rustgi AK
    Cancer Res; 2000 Jun; 60(11):2836-9. PubMed ID: 10850424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.
    Launonen V; Laake K; Huusko P; Niederacher D; Beckmann MW; Barkardottir RB; Geirsdottir EK; Gudmundsson J; Rio P; Bignon YJ; Seitz S; Scherneck S; Bièche I; Champème MH; Birnbaum D; White G; Varley J; Sztán M; Olah E; Osorio A; Benitez J; Spurr N; Velikonja N; Peterlin B; Winqvist R
    Br J Cancer; 1999 May; 80(5-6):879-82. PubMed ID: 10360669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of heterozygosity in laryngeal cancer.
    Rogowski M; Walenczak I; Pepiński W; Skawrońska M; Sieśkiewicz A; Klatka J
    Rocz Akad Med Bialymst; 2004; 49():262-4. PubMed ID: 15631354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
    Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
    Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
    Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found.
    Hartikainen JM; Tuhkanen H; Kataja V; Dunning AM; Antoniou A; Smith P; Arffman A; Pirskanen M; Easton DF; Eskelinen M; Uusitupa M; Kosma VM; Mannermaa A
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):75-80. PubMed ID: 15668479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.